AHA scientific statement provides a framework for standardizing baseline and provocative invasive hemodynamic protocols in HF ...
China NMPA approves Sanofi’s Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome: Paris Saturday, January 17, 2026, 11:00 Hrs ...
DelveInsight's Underactive Bladder Syndrome Market Insights report includes a comprehensive understanding of current treatment practices, underactive bladder syndrome emerging drugs, market share of ...
German chamomile extract shows promise in lowering high blood pressure by relaxing blood vessels. Lab & animal studies reveal it modulates calcium channels & key proteins, likely due to compounds like ...